Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
J&J to acquire drugmaker Intra-Cellular Therapies for $14.6 billion
The deal is the latest in a string of acquisitions by J&J as it looks to drive growth beyond 2025
LTIMindtree bags multimillion dollar contract extension with Absa Bank
This strengthened partnership solidifies LTIMindtree's leadership in the banking, financial services, and insurance (BFSI) sector
Johnson Controls Apac president bullish on India's 'sustainable' demand
While the Paris Agreement has accelerated clients' sustainability agenda, Rathninde believes it is much more than that
Johnson Controls launches tech centre in Bengaluru, will step up hiring
Company for smart and sustainable buildings will help clients achieve net zero carbon emissions
Johnson and Johnson: Why talc-based powder will stop their sales in 2023?
After 38,000 serious allegations, Johnson and Johnson's talc-based baby powder will stop international sales from 2023. The product has already been discontinued in the US and Canada
Johnson Controls-Hitachi JV sets up global development centre in Gujarat
GDC at Kadi is the company's fourth globally, after two in Japan and one in China
Johnson turns up the speed, hopes for a smooth ride
It has pitted itself against MNCs Schindler, Otis; and hopes to grab larger share of fast growing market
